ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

In Brief: NIH Appeals Board Restores Nassau CCOP Funding, PI Says It Is Now Meeting Patient Accrual Goal

February 22, 1985

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

November 21, 1975

Schweiker Approves Transfer Of NTP’s NNCI Contribution To NIESH In FY’83

July 31, 1981

AACR Presents Awards At Annual Meeting

April 23, 2010

Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation

November 27, 1987